Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Financial Data By Reportable Segment

Financial data by reportable segment for the three months ended March 31, 2020 and 2019 is as follows:

	Commercial & Specialty Business		Government Business		IngenioRx		Other			Eliminations			Total
Three Months Ended March 31, 2020
Operating revenue - unaffiliated	$	9,361	$	17,466	$	2,344	$	277		$	—		$	29,448
Operating revenue - affiliated	—		—		2,853		750			(3,603		)	—
Operating gain	1,420		411		349		14			—			2,194
Three Months Ended March 31, 2019
Operating revenue - unaffiliated	$	9,392	$	14,925	$	—	$	71		$	—		$	24,388
Operating revenue - affiliated	—		—		—		477			(477		)	—
Operating gain (loss)	1,598		374		—		(32		)	—			1,940

Major Product Revenue by Segment

The major product revenues for each of the reportable segments for the three months ended March 31, 2020 and 2019 are as follows:

	Three Months Ended   March 31
	2020			2019
Commercial & Specialty Business
Managed care products	$	7,569		$	7,618
Managed care services	1,381			1,366
Dental/Vision products and services	315			323
Other	96			85
Total Commercial & Specialty Business	9,361			9,392
Government Business
Managed care products	17,375			14,821
Managed care services	91			104
Total Government Business	17,466			14,925
IngenioRx
Pharmacy products and services	5,197			—
Total IngenioRx	5,197			—
Other
Other	1,027			548
Eliminations
Eliminations	(3,603		)	(477		)
Total product revenues	$	29,448		$	24,388

Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three months ended March 31, 2020 and 2019 is as follows:

	Three Months Ended   March 31
	2020			2019
Reportable segments’ operating revenue	$	29,448		$	24,388
Net investment income	254			210
Net realized (losses) gains on financial instruments	(24		)	78
Impairment losses recognized in income	(57		)	(10		)
Total revenues	$	29,621		$	24,666

Reconciliation Of Reportable Segments Operating Gain To Income Before Income Tax Expense Included In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the three months ended March 31, 2020 and 2019 is as follows:

	Three Months Ended   March 31
	2020			2019
Reportable segments’ operating gain	$	2,194		$	1,940
Net investment income	254			210
Net realized (losses) gains on financial instruments	(24		)	78
Impairment losses recognized in income	(57		)	(10		)
Interest expense	(194		)	(187		)
Amortization of other intangible assets	(83		)	(87		)
(Loss) gain on extinguishment of debt	(1		)	1
Income before income tax expense	$	2,089		$	1,945